This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Breast Cancer
and you are
The phase for this study is not defined.
Show me locations

The purpose

Seroma is a common complication following modified radical mastectomy(MRM). Closed drainage is used routinely to reduce incidence of seroma. Usually two drains are used in patients who underwent MRM to reduce post operative seroma. It is often associated with significant patient discomfort and prolonged fluid drainage. The aim of this study is to evaluate effect of number of drains on seroma formation rate, postoperative pain and hospital stay during the immediate postoperative period after mastectomy for breast cancer.

Provided treatments

  • Device: Drain
Tris trial is registered with FDA with number: NCT02411617. The sponsor of the trial is Memon Medical Institute and it is looking for 176 volunteers for the current phase.
Official trial title:
Single vs. Double Drain in Modified Radical Mastectomy: A Randomized Control Trial